Lambda Light Chain

Lambda light chains are one of the two types of immunoglobulin light chains (the other is kappa). They are produced by B cells and plasma cells and circulate either bound to heavy chains (as part of intact antibodies) or as free light chains (FLCs) in serum and urine.

1. Marker of Plasma Cell Disorders

An excess of λ light chains—especially as free lambda light chains—is strongly associated with monoclonal plasma cell proliferations, such as:

• Multiple myeloma (λ-type)
• Light-chain myeloma
• AL (primary) amyloidosis

Monoclonal gammopathy of undetermined significance (MGUS)

➡️ A skewed kappa:lambda ratio suggests monoclonality, a hallmark of plasma cell dyscrasia.

2. Diagnostic Importance (Serum Free Light Chain Assay)

Normal κ:λ ratio ≈ 0.26–1.65

Low ratio → excess λ light chains

High ratio → excess κ light chains

This assay is especially useful when:

No M-protein is detected on serum protein electrophoresis

Disease secretes only light chains

Early diagnosis or relapse detection is needed

3. Renal Involvement

Excess λ light chains can be filtered by the kidneys and cause:

• Light chain cast nephropathy
• Tubular toxicity
• Progressive renal failure

Free λ light chains may appear in urine as Bence Jones proteins.

4. Role in Amyloidosis

λ light chains are more commonly involved than κ in AL amyloidosis

They misfold and deposit as amyloid fibrils in organs such as:

• Kidney
• Heart
• Liver
• Peripheral nerves

5. Disease Monitoring & Prognosis

Levels of free λ light chains fall with effective therapy

Rising levels suggest:

• Disease progression
• Relapse
• Extremely high levels are often associated with poor prognosis, particularly when renal failure is present

6. Polyclonal Elevation (Non-malignant Causes)

Mild increases in λ light chains (with a normal κ:λ ratio) can occur in:

Chronic infections

Autoimmune diseases

Liver disease

Chronic kidney disease (due to reduced clearance)

➡️ These reflect polyclonal immune activation, not malignancy.